Ignite Creation Date:
2025-12-24 @ 9:43 PM
Ignite Modification Date:
2026-01-02 @ 7:33 PM
Study NCT ID:
NCT02292732
Status:
WITHDRAWN
Last Update Posted:
2016-01-26
First Post:
2014-11-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Pharmacokinetics (PK) and Safety Study to Determine the Effect of Repeat Dosing of Trametinib on Combined Oral Contraceptive (Norethindrone Plus Ethinyl Estradiol) in Female Subjects With Solid Tumors
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02
Start Date Type:
None
Primary Completion Date:
2017-05
Primary Completion Date Type:
ESTIMATED
Completion Date:
2017-05
Completion Date Type:
ESTIMATED
First Submit Date:
2014-11-13
First Submit QC Date:
None
Study First Post Date:
2014-11-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-01-25
Last Update Post Date:
2016-01-26
Last Update Post Date Type:
ESTIMATED